Matches 1 - 50 out of 83 1 2 >


Match Document Document Title
US20130209560 ABUSE-RESISTANT FORMULATIONS  
This disclosure relates to a sustained-release oral dosage form suitable for twice-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing...
US20120225122 Abuse-Resistant Formulations  
This disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing hydromorphone. The...
US20110171302 METHOD FOR TREATING NEURODEGENERATIVE DISORDERS WITH ORAL DOSAGE FORMULATION CONTAINING BOTH IMMEDIATE-RELEASE AND SUSTAINED-RELEASE DRUGS  
Disclosed herein is a method for treating patient suffering from a disorder related to central nervous system with an oral dosage formulation that contains both sustained-release and...
US20070053981 Solid composition comprising a proton pump inhibitor  
The present invention related to a method for oral administration of a solid composition comprising an acid labile proton pump inhibitor compound in the form of a multiple of enteric coating...
US20080254120 ORALLY-DISINTEGRATING TABLET AND MANUFACTURING METHOD THEREOF  
An orally-disintegrating tablet comprises a principal agent, a sugar alcohol powder and a sugar alcohol granule, wherein the orally-disintegrating tablet has a hardness of 30 N or greater....
US20070065513 Stable lansoprazole formulation  
A stable composition comprising a substrate comprising lansoprazole (preferably in the base form), without any alkaline agent; a subcoating layer containing alkaline agent; and an enteric coating...
US20070292509 ENTERIC COATED GRANULE AND METHOD FOR PREPARING THE SAME  
The present invention is an enteric coated granule having controlled dissolution in water even at a small coating amount; and a preparation method thereof. More specifically, provided are an...
US20070071821 Formulation for providing an enteric coating material  
The present invention relates to an enteric coating formulation, as well as methods for preparing and using said enteric coating formulation. In particular, the invention relates to an enteric...
US20060153917 Enteric coated bead comprising ixabepilone, and preparation and administration thereof  
Disclosed is an enteric coated bead comprising Ixabepilone, a compound having a structure Also disclosed is a capsule comprising a multitude of the enteric coated beads. Further, a method of...
US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture  
There is provided a method for preparing a pharmaceutical composition comprising compressible coated, taste-masked and/or controlled-release coated drug-containing particles, rapidly-dispersing...
US20090148524 METHOD OF PRODUCING SOLID PREPARATION DISINTEGRATING IN THE ORAL CAVITY  
It is intended to provide a method of producing a solid preparation disintegrating in the oral cavity characterized by comprising mixing fine subtilaes containing a medicinal ingredient with an...
US20070134329 Venlafaxine Formulations and Methods of Preparing the Same  
A method of forming a multi-particulate dosage form using rotary granulation is described in which polyethylene oxide is employed as s binder in a rotary granulation process. A multi-particulate...
US20050175698 Multiparticulate O-desmethylvenlafaxine salts and uses thereof  
A multiparticulate O-desmethylvenlafaxine (ODV) succinate or formate is described. Methods of treating depression and reducing the gastrointestinal side-effects of ODV are also described.
US20070134315 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound  
Pharmaceutical compositions comprising an extended release formulation of active compounds effective in the treatment of various pathological conditions are provided. More particularly, the...
US20050106250 Protected active compound formulations of amino acids and process for their preparation  
Active compound formulations for animal nutrition of amino acids, vitamins, enzymes and pigments, which are suitable for providing the active compounds in protected form for the nutrition of stock...
US20070202169 Lansoprazole orally disintegrating tablets  
The invention provides orally disintegrating tablets that readily disintegrates in the mouth, releasing enteric coated drug sub-tablets.
US20080113025 COMPOSITIONS COMPRISING NANOPARTICULATE NAPROXEN AND CONTROLLED RELEASE HYDROCODONE  
The invention relates to a compositions comprising a nanoparticulate naproxen composition in combination with a multiparticulate modified release hydrocodone composition that, upon administration...
US20070207205 Rapidly Disintegrating Taste-Masked Tablet  
The present invention concerns a rapidly disintegrating taste-masked tablet having both hardness and non-friability properties comprising at least one active principle selected from the group of...
US20070298106 Sustained Release Formulation Containing Selective Serotonin Reuptake Inhibitor and Method for the Preparation Thereof  
A sustained release formulation of a selective serotonin reuptake inhibitor (SSRI), comprising the SSRI as an active ingredient; a matrix comprising a water-soluble and erodible polymer, a...
US20080107726 COMPOSITIONS COMPRISING BETA-ADRENERGIC RECEPTOR ANTAGONISTS AND DIURETICS  
Pharmaceutical compositions comprise beta-adrenergic receptor blocking agents for controlled release and diuretics for immediate release. In an embodiment, a composition comprising metoprolol...
US20050175696 Drug granule coatings that impart smear resistance during mechanical compression  
A drug formulation is disclosed comprising granules having a substrate and a coating, said granule substrate comprising a solubilizing surfactant or a low solubility therapeutic drug, or both, and...
US20060210631 Multi-particulate, modified-release composition  
A multi-particulate, modified-release pharmaceutical composition for the oral administration of an active ingredient to the colon, wherein said particles comprise: (a) a core comprising an active...
US20070292510 ENTERIC COATED PARTICLES CONTAINING AN ACTIVE INGREDIENT  
Enterically coated particles and chewable tablets made therefrom are disclosed. The enterically coated particles are comprised of a core containing an active ingredient, a first coating layer...
US20060083786 Taste masking pharmaceutical composition containing levocetirizine  
A solid oral dosage composition is provided comprising a prophilactically or therapeutically effective amount of an active pharmaceutical ingredient comprising levocetirizine or a pharmaceutically...
US20080279938 ZALTOPROFEN-CONTAINING SUSTAINED RELEASE TABLET AND PROCESS FOR THE PREPARATION THEREOF  
Disclosed is a zaltoprofen-containing sustained release tablet comprising granules containing zaltoprofen and a binder, in which the granules are dispersed in a matrix comprising a hydrophilic...
US20100143468 Tranexamic Acid Formulations  
Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
US20060286168 Process for producing coated preparation  
The present invention provides a production method of a preparation coated with pioglitazone hydrochloride, which is useful as a therapeutic agent for diabetes and the like and superior in the...
US20070036857 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin  
The present invention relates to a novel composition of mycophenolic acid, a salt or a prodrug thereof and to a fixed combination of mycophenolic acid, a salt or a prodrug thereof and rapamycin or...
US20060003005 Tablet for pulsed delivery  
A pharmaceutical tablet comprising an immediate release portion containing an active ingredient and a delayed release portion, wherein the delayed release portion comprises an enteric-coated layer...
US20060159757 Pharmaceutical composition for controlled release of beta-lactam antibiotics in combination with beta-lactamase inhibitors  
The invention relates to a pharmaceutical composition containing a β-lactam antibiotic and/or a pharmaceutically tolerable salt thereof in the form of coated pellets that may optionally contain a...
US20080213339 Pharmaceutical Composition Containing Indometacin and/or Acemetacin  
The invention relates to a pharmaceutically active composition or pharmaceutical form of administering that contains at least one of the active ingredients indomethacin or acemetacin and...
US20060147531 Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate  
The present invention is directed to a sustained/release pharmaceutical composition containing Tamsulosin and having a reduced food effect.
US20050118266 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping  
A sustained/controlled release formulation with reduced risk of dose dumping and side effects combines two components: component (a) comprises a pharmaceutically active agent and a...
US20070154549 Multiparticulate formulations for oral delivery  
The present invention is directed to multiparticulate formulations for oral use, preferably comprising one or more therapeutically active agents. In particular, the present invention relates to...
US20060280793 Oral sustained-release preparation of fasudil hydrochloride  
Disclosed is an oral sustained-release preparation which contains at least one active-ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof, the preparation...
US20070014859 Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate  
An oral, highly bioavailable unit dosage form of O-desmethylvenlafaxine succinate (DVS) having a delayed release of at least about one hour and a sustained release over multiple hours to provide a...
US20060115526 Venlafaxine compositions comprising pellets with double layer coating  
This invention provides coated pellets comprising a) a pellet core which comprises venlafaxine hydrochloride; b) a first coating which comprises a lipophilic layer or a sparingly water-soluble...
US20120003311 METHOD FOR CONTROLLED RELEASE OF AN ACID-UNSTABLE PHYSIOLOGICALLY ACTIVE SUBSTANCE  
It is an object of the present invention, in the case of a controlled-release pharmaceutical composition, particularly a pulsed-release pharmaceutical composition, containing an acid-unstable...
US20090068260 BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION  
The present invention provides extended release pharmaceutical compositions of a beta blocker such as, but not limited to, metoprolol succinate as the active ingredient, optionally also comprising...
US20080057118 DIVALPROEX PHARMACEUTICAL COMPOSITIONS  
Pharmaceutical compositions comprising a valproic acid drug compound, providing modified release of the drug.
US20050095294 Modafinil modified release pharmaceutical compositions  
Pharmaceutical compositions comprising modafinil. The pharmaceutical compositions can have a release profile which is different than that of traditional pharmaceutical compositions of modafinil.
US20050106251 Zero order controlled drug delivery system  
A controlled release dosage form comprising: (i) a tablet core comprising a pharmaceutically active ingredient and one or more pharmaceutically acceptable matrix forming polymers, (ii) a...
US20060198889 Roflumilast and integrin inhibitor combination and treatement method  
The present invention provides novel solid pharmaceutical dosage forms for oral administration comprising a therapeutically active amount of roflumilast, or a pharmaceutically acceptable salt...
US20150064251 Tamper Resistant Dosage Form Composition And Process Of Making The Same  
A tamper-resistant dosage form including a therapeutic agent-substrate complex embedded in a thermo-formable matrix; such that the complex includes at least one therapeutic agent bound to at least...
US20080026060 CONTROLLED-RELEASE PHARMACEUTICAL TABLETS  
Controlled-release tablets exhibiting excellent storage stability are achieved by granulating a pharmaceutically active agent with a hydroxyalkylcelluose, blending the resulting granules with an...
US20070026066 Oral pharmaceutical delivery system with improved sustained release  
A solid orally ingested delivery system having at least one lipid, dry particles including at least one pharmaceutical, and at least one filler, where the dry particles are continuously coated by...
US20060057200 Tablets with site- and time-controlled gastrointestinal release of active ingredient  
The present invention describes a pharmaceutical dosage form with site- and time-controlled gastrointestinal release of active ingredient.
US20150064250 Tamper-Resistant Pharmaceutical Dosage Forms  
The invention provides a tamper-resistant dosage form including a therapeutic agent-substrate complex embedded in a thermo-formable matrix; such that the complex includes at least one therapeutic...
US20050129760 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation  
The present invention relates to oral pharmaceutical preparations in the form of pellets in which a benzimidazole compound is stabilized by combining it with microcrystalline cellulose.
US20050129762 Extended release pharmaceutical dosage form  
This invention relates to novel extended release pharmaceutical dosage forms for orally delivering drugs to mammals, e.g., humans. More particularly, this invention concerns novel dosage forms of...

Matches 1 - 50 out of 83 1 2 >